Skip to main content

Harvard’s Headache Cure: LSD?

Submitted by dguard on
Harvard researcher John Halpern has formed a company he hopes will bring to market a drug based on his research into the effects of lysergic acid diethylamide on cluster headaches, a rare but devastating condition that is as bad as it sounds. Halpern, a noted expert in the long-term effects of drug use, said research suggests chemicals present in LSD are an astonishingly effective cure for cluster headaches. Entheogen’s drug does not cause triptastic visions, Halpern said -- it is based on BOL-148, a non-hallucinogenic LSD derivative developed in the 1950s and 60s for research into the effects of LSD on the brain, when such was last in vogue.

Add new comment

The content of this field is kept private and will not be shown publicly.
About text formats
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
LSD
Business
Academics
Permission to Reprint: This content is licensed under a modified Creative Commons Attribution license. Content of a purely educational nature in Drug War Chronicle appear courtesy of DRCNet Foundation, unless otherwise noted.